IRhythm EBITDA Margin from 2010 to 2024
| IRTC Stock | USD 109.48 3.64 3.22% |
Check IRhythm Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IRhythm main balance sheet or income statement drivers, such as Depreciation And Amortization of 23.3 M, Interest Expense of 2.6 M or Selling General Administrative of 404.9 M, as well as many exotic indicators such as Price To Sales Ratio of 12.31, Dividend Yield of 0.0036 or PTB Ratio of 8.9. IRhythm financial statements analysis is a perfect complement when working with IRhythm Technologies Valuation or Volatility modules.
IRhythm | EBITDA Margin |
About IRhythm Technologies Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include IRhythm Technologies income statement, its balance sheet, and the statement of cash flows. IRhythm Technologies investors use historical funamental indicators, such as IRhythm Technologies's EBITDA Margin, to determine how well the company is positioned to perform in the future. Although IRhythm Technologies investors may use each financial statement separately, they are all related. The changes in IRhythm Technologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on IRhythm Technologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on IRhythm Technologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in IRhythm Technologies. Please read more on our technical analysis and fundamental analysis pages.
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram monitoring products for patients at risk for arrhythmias in the United States. The company was incorporated in 2006 and is headquartered in San Francisco, California. Irhythm Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1700 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of IRhythm Technologies Correlation against competitors. For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for IRhythm Stock analysis
When running IRhythm Technologies' price analysis, check to measure IRhythm Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRhythm Technologies is operating at the current time. Most of IRhythm Technologies' value examination focuses on studying past and present price action to predict the probability of IRhythm Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRhythm Technologies' price. Additionally, you may evaluate how the addition of IRhythm Technologies to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is IRhythm Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRhythm Technologies. If investors know IRhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IRhythm Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.04) | Revenue Per Share 16.139 | Quarterly Revenue Growth 0.177 | Return On Assets (0.14) | Return On Equity (0.55) |
The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IRhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRhythm Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.